Search

Your search keyword '"William, F."' showing total 1,573 results

Search Constraints

Start Over You searched for: Author "William, F." Remove constraint Author: "William, F." Publication Type News Remove constraint Publication Type: News
1,573 results on '"William, F."'

Search Results

1. A Reorganization By Any Other Name Would Smell As Sweet . . . Or Maybe Not

2. FinCEN Publishes Filing Extension For BOI Reporting

3. Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged [greater than or equal to]18 Years with Immunocompromising Conditions--VISION Network, September 2023-February 2024

5. Chevron Deference's End Changes Washington's Status Quo for the Better

6. Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19--Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions--VISION Network, September 2022-April 2023

7. Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance--VISION Network, 10 States, December 2021-August 2022

8. Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated--VISION Network, 10 States, December 2021-June 2022

9. Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance--VISION Network, 10 States, August 2021-January 2022

10. Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19--Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance--VISION Network, 10 States, August 2021-January 2022

11. FTC Extends Deadline To Comment On 10-Year Update To Green Guides

12. Multiple Claims Against Insured Related To COVID-19 Outbreak Constitute Separate Claims

13. Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults--Nine States, January-September 2021

14. Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity--Nine States, January-September 2021

15. Delaware Federal Court: No Coverage Under D&O Policy For Claims Based On Acts Alleged To Have Occurred Prior To Insured Entity's Formation

16. Staking A Climate Claim

17. Uber Loses Appeal Challenging $91 Million In Mass Arbitration Fees

18. Why the Biden administration's recommendation on booster shots is a mistake

19. Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample-Indiana, April 25-29, 2020

20. Delay 2nd shots, get 1st doses into arms

21. How U.S. allies in the Gulf can help prevent an Iranian October surprise

22. Proposed New York Biometric Privacy Act Allows Private Right Of Action

23. When 'home' finally starts to feel like it

24. Sports, please come back

25. An ode to my grandmother

26. Building friendships over Zoom

27. Iran may be tempted to try an 'October surprise.' Here's how Trump can be prepared

28. Six Cases of Acute Flaccid Myelitis in Children--Minnesota, 2018

29. Facilitative Mediation And Client Communication

30. Viewpoint: Why Medical Marijuana Laws Are Not A Gateway To Adult Use Legislation

31. THE STORY LEFT OUT OF 'SPOTLIGHT'

32. Dynamic business continues based on a variety of factors.

33. House Tax Bill Eliminates Tax-Exempt 501(c)(3) Bonds

34. Emphasis on incentives: rewarding sales performance.

35. Selling against non-bank competitors.

36. LEARNING TO THINK CRITICALLY FOR YOURSELF

37. Roads to ruin

38. My View: William F. Fulginiti

39. Managing a trust sales team: realities of the marketplace.

40. Second circuit provides guidance on the nature of disclosures that will avoid liability for market manipulation

41. FCPA update: the DOJ's recent enforcement activities

42. Ninth Circuit curbs the rising tide of subprime litigation and rejects a private right of action for violation of investment objectives under the Investment Company Act of 1940

43. Business and Commercial Litigation in Federal Courts, 3d.

44. MY VIEW: WILLIAM F. BOWMAN OIL DEPOT HAS NO PLACE IN LAMY

45. Ruling to create major concerns for some commercial lenders.

46. Sales calls in a multi-call environment.

47. The power of inter-religious cooperation to transform conflict

48. Bringing the outside to the inside.

49. Recent developments in business lending by commercial banks

50. Profits and balance sheet developments at U.S. commercial banks in 2001

Catalog

Books, media, physical & digital resources